Kanda Sangthongpitag

1.4k total citations
25 papers, 827 citations indexed

About

Kanda Sangthongpitag is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Kanda Sangthongpitag has authored 25 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Oncology and 3 papers in Genetics. Recurrent topics in Kanda Sangthongpitag's work include Peptidase Inhibition and Analysis (7 papers), Histone Deacetylase Inhibitors Research (7 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). Kanda Sangthongpitag is often cited by papers focused on Peptidase Inhibition and Analysis (7 papers), Histone Deacetylase Inhibitors Research (7 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). Kanda Sangthongpitag collaborates with scholars based in Singapore, Australia and United States. Kanda Sangthongpitag's co-authors include Vishal Pendharkar, Jeffrey Hill, Thomas H. Keller, Soo Yei Ho, Jenefer Alam, Esther Ong, Babita Madan, David M. Virshup, Vithya Manoharan and Duraiswamy A. Jeyaraj and has published in prestigious journals such as Blood, Oncogene and Journal of Medicinal Chemistry.

In The Last Decade

Kanda Sangthongpitag

25 papers receiving 812 citations

Peers

Countries citing papers authored by Kanda Sangthongpitag

Since Specialization

Citations

This map shows the geographic impact of Kanda Sangthongpitag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanda Sangthongpitag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanda Sangthongpitag more than expected).

Fields of papers citing papers by Kanda Sangthongpitag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kanda Sangthongpitag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanda Sangthongpitag. The network helps show where Kanda Sangthongpitag may publish in the future.

Co-authorship network of co-authors of Kanda Sangthongpitag

This figure shows the co-authorship network connecting the top 25 collaborators of Kanda Sangthongpitag. A scholar is included among the top collaborators of Kanda Sangthongpitag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanda Sangthongpitag. Kanda Sangthongpitag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of dual GyrB/ParE inhibitors active against Gram-negative bacteria 2018 ·European Journal of Medicinal Chemistry ·Soo Yei Ho, Weiling Wang, Fui Mee Ng, (unknown), (unknown), (unknown), Shi Hua Ang, Si Si Liew, (unknown), Yvonne Tze Fung Tan, Anders Poulsen, Vishal Pendharkar, Kanda Sangthongpitag, John I. Manchester, Gregory S. Basarab, Jeffrey Hill, Thomas H. Keller, Joseph Cherian	11
2	Scaffold Hopping and Optimization of Maleimide Based Porcupine Inhibitors 2017 ·Journal of Medicinal Chemistry ·Soo Yei Ho, Jenefer Alam, Duraiswamy A. Jeyaraj, Weiling Wang, Grace Lin, Shi Hua Ang, (unknown), May Ann Lee, Zhiyuan Ke, Babita Madan, David M. Virshup, Li Ding, Vithya Manoharan, (unknown), (unknown), Vishal Pendharkar, Kanda Sangthongpitag, Jeffrey Hill, Thomas H. Keller, Anders Poulsen	26
3	Towards Selective Mycobacterial ClpP1P2 Inhibitors with Reduced Activity against the Human Proteasome 2017 ·Antimicrobial Agents and Chemotherapy ·Wilfried Moreira, (unknown), Grace Ngan, (unknown), Kanda Sangthongpitag, Anders Poulsen, Brian Dymock, Thomas Dick	25
4	p53 Maintains Genomic Stability by Preventing Interference between Transcription and Replication 2016 ·Cell Reports ·(unknown), (unknown), (unknown), Shuhui Lim, (unknown), Ramesh Kumar, Kanda Sangthongpitag, Vishal Pendharkar, Vincent H.B. Ho, Chit Fang Cheok	72
5	Discovery and Optimization of a Porcupine Inhibitor 2015 ·Journal of Medicinal Chemistry ·(unknown), May Ann Lee, Babita Madan, Shi Hua Ang, (unknown), (unknown), Zhiyuan Ke, Vishal Pendharkar, Li Ding, (unknown), Vithya Manoharan, Kanda Sangthongpitag, Jenefer Alam, Anders Poulsen, Soo Yei Ho, David M. Virshup, Thomas H. Keller	32
6	Wnt addiction of genetically defined cancers reversed by PORCN inhibition 2015 ·Oncogene ·Babita Madan, (unknown), Nathan Harmston, Soo Yei Ho, (unknown), Jenefer Alam, Duraiswamy A. Jeyaraj, Vishal Pendharkar, (unknown), Isaac Virshup, Vithya Manoharan, Esther Ong, Kanda Sangthongpitag, Jeffrey Hill, Enrico Petretto, Thomas H. Keller, (unknown), A. Matter, David M. Virshup	271
7	Feedback regulation on PTEN/AKT pathway by the ER stress kinase PERK mediated by interaction with the Vault complex 2014 ·Cellular Signalling ·Wei Zhang, Suat Peng Neo, Jayantha Gunaratne, Anders Poulsen, Bo Liu, Esther Ong, Kanda Sangthongpitag, Vishal Pendharkar, Jeffrey Hill, Stephen M. Cohen	31
8	Combination treatment for myeloproliferative neoplasms using JAK and pan‐class I PI3K inhibitors 2013 ·Journal of Cellular and Molecular Medicine ·Meng Ling Choong, C. Pecquet, Vishal Pendharkar, Carmen C. Diaconu, (unknown), Shi Tai, (unknown), Jean‐Philippe Defour, Kanda Sangthongpitag, Jean‐Luc Villeval, William Vainchenker, Stefan N. Constantinescu, May Ann Lee	46
9	Preclinical Metabolism and Disposition of SB939 (Pracinostat), an Orally Active Histone Deacetylase Inhibitor, and Prediction of Human Pharmacokinetics 2011 ·Drug Metabolism and Disposition ·Ramesh Jayaraman, Venkatesh Pilla Reddy, Mohammad Pasha, Haishan Wang, Kanda Sangthongpitag, Pauline Yeo, (unknown), Xiaofeng Wu, Xin Liu, (unknown), Lee Sun New, Kantharaj Ethirajulu	17
10	SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer 2010 ·Molecular Cancer Therapeutics ·Veronica Novotny‐Diermayr, Kanda Sangthongpitag, (unknown), Xiaofeng Wu, Nina Sausgruber, Pauline Yeo, Gediminas Greicius, Sven Pettersson, (unknown), Yung Kiang Loh, Zahid Bonday, Kee Chuan Goh, Hannes Hentze, Stefan Hart, Haishan Wang, Kantharaj Ethirajulu, Jeanette M. Wood	109
11	Acylurea connected straight chain hydroxamates as novel histone deacetylase inhibitors: Synthesis, SAR, and in vivo antitumor activity 2010 ·Bioorganic & Medicinal Chemistry Letters ·Haishan Wang, (unknown), Yan Zhou, (unknown), Ting Lu, Ken Lee, Kanda Sangthongpitag, Kee Chuan Goh, Xukun Wang, Xiaofeng Wu, (unknown), (unknown), (unknown), Zahid Bonday, Eric T. Sun	24
12	In Vitro Phase I Cytochrome P450 Metabolism, Permeability and Pharmacokinetics of SB639, a Novel Histone Deacetylase Inhibitor in Preclinical Species 2007 ·Biological and Pharmaceutical Bulletin ·(unknown), (unknown), (unknown), Lee Sun New, Xin Liu, Mohammad Pasha, Kanda Sangthongpitag, Pauline Yeo, Kantharaj Ethirajulu	22
13	SB1317, a Potent and Orally Active FLT3-CDK Inhibitor with High Anti-Tumor Efficacy in Models of Hematological Malignancies. 2007 ·Blood ·Kee Chuan Goh, (unknown), Changyong Hu, (unknown), Walter Stünkel, Yong Tan, Kanda Sangthongpitag, (unknown), Zahid Bonday, Anthony D. William, Brian Dymock, Kantharaj Ethirajulu, Jeanette M. Wood	3
14	Pharmacokinetic and Pharmacodynamic Properties of SB1317, a Potent and Orally Active Multi-Kinase Inhibitor. 2007 ·Blood ·Pauline Yeo, Venkatesh Paramesh, (unknown), (unknown), Lee Sun New, Changyong Hu, Kanda Sangthongpitag, Anthony D. William, Kee Chuan Goh, Jeanette M. Wood, Kantharaj Ethirajulu	1
15	SB1518: A Potent and Orally Active JAK2 Inhibitor for the Treatment of Myeloproliferative Disorders. 2007 ·Blood ·Kee Chuan Goh, (unknown), Changyong Hu, Hannes Hentze, (unknown), Walter Stünkel, Yong Tan, Kanda Sangthongpitag, (unknown), Shirly Sieh, Zahid Bonday, Anthony D. William, (unknown), Stéphanie Blanchard, (unknown), Martin Sattler, James D. Griffin, Brian Dymock, Kantharaj Ethirajulu, Jeanette M. Wood	11
16	162 POSTER Pharmacological profile of SB939, a novel, potent and orally active histone deacetylase inhibitor 2006 ·European Journal of Cancer Supplements ·Kanda Sangthongpitag, Xiaofeng Wu, (unknown), (unknown), Pui Yee Ng, (unknown), Zahid Bonday, Haishan Wang, J M Wood, Michael Entzeroth	2
17	Complete molecular scanning of the human Fas gene: mutational analysis and linkage studies in families with Type I diabetes mellitus 2000 ·Diabetologia ·(unknown), Ole Peter Kristiansen, Kanda Sangthongpitag, (unknown), Jesper Johannesen, (unknown), Flemming Pociot, Jørn Nerup, Charles F. Verge, Thomas Mandrup‐Poulsen	17
18	No Evidence for Linkage of a Novel CA Repeat Polymorphism for Apoptosis Antigen 1 (APO-1 or Fas) with Type I Diabetes in a Caucasian Population 1998 ·Human Heredity ·Kanda Sangthongpitag, (unknown), Naras M. Lapsys, Fei Bao, Sunanda Babu, Pamela R. Fain, Charles F. Verge	1
19	Cloning and expression of the Bacillus sphaericus 2362 mosquitocidal genes in a non-toxic unicellular cyanobacterium, Synechococcus PCC6301 1997 ·Applied Microbiology and Biotechnology ·Kanda Sangthongpitag, Robert J. Penfold, (unknown), Peter L. Rogers	17
20	Evaluation of four fresh-water unicellular cyanobacteria as potential hosts for mosquitocidal toxins 1996 ·Biotechnology Letters ·Kanda Sangthongpitag, (unknown), Peter L. Rogers	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact